• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Skin That “Changed Overnight”

Article

Mottled skin; neuropathic pain; syncope . . . test yourself on these and other subjects.

Question 1:

These lesions appeared “overnight” on the leg of a 66-year-old black woman who was caring for her mother who had been hospitalized.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 2:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 3:

Familial adenomatous polyposis was diagnosed in a 26-year-old man whose father and grandfather had colon cancer when they were in their 40s.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 4:

Brugada syndrome was diagnosed in a 15-year-old boy after a syncopal episode experienced when he was playing football.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 5:

A 54-year-old man had acute onset of a painful scrotal rash.

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. B

Question 2. A

Question 3. F

Question 4. E

Question 5. D

Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship / image credit Jill Pell, MD, CBE, Courtesy of the University of Glasgow

Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship

Grace Halsey
November 17th 2025
Article

Individuals who have chronic widespread pain showed a 75% increased risk of developing hypertension compared to fellow UK Biobank participants who were pain-free.

Obesity & Pain Management: A Primary Viewpoints Podcast

Obesity & Pain Management: A Primary Viewpoints Podcast

Sydney Jennings
April 27th 2023
Podcast

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

GLP-1 Receptor Agonist GI Safety Comparable Within the Class, But Exceeds SGLT-2 Inhibitor Risk / image credit/ Elisabetta Patorno, MD, DrPH Courtesy of Harvard Medical School

GLP-1 Receptor Agonist GI Safety Comparable Within the Class, But Exceeds SGLT-2 Inhibitor Risk

Grace Halsey
November 4th 2025
Article

The real-world study of 200,000+ adults found no GI safety differences among 3 GLP-1 drugs for T2D, however SGLT-2 inhibitors are safer for motility issues.

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Sydney Jennings
September 29th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Undertreated Acute Pain Poses Long-Term Risks, But So Do Prescription Opioids / image credit ©Sjstudio6/stock.adobe.com

Undertreated Acute Pain Poses Long-Term Risks, But Prescription Opioids Still Do, Too ...

Grace Halsey
October 17th 2025
Article

Undertreated acute pain can lead to life-long chronic pain but there are still few effective opioid-sparing options. A new review reinforces the persistent safety issues.

FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment / Image credit: ©unlimit3d/AdobeStock

FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment

Sydney Jennings
October 14th 2025
Article

FDA approves updated indication for upadacitinib in ulcerative colitis and Crohn disease treatment, allowing use after one systemic therapy when TNF blockers are clinically inadvisable.

© 2025 MJH Life Sciences

All rights reserved.